VESPRO: Statistical Report
Access status:
Open Access
Type
Report, TechnicalAbstract
An individual patient data prospective meta-analysis (IPD_PMA) of selective internal radiation therapy (SIRT) versus sorafenib for advanced, locally advanced or recurrent hepatocellular carcinoma (HCC) of the SARAH and SIRveNIB trialsAn individual patient data prospective meta-analysis (IPD_PMA) of selective internal radiation therapy (SIRT) versus sorafenib for advanced, locally advanced or recurrent hepatocellular carcinoma (HCC) of the SARAH and SIRveNIB trials
See less
See less
Date
2023-06-29Licence
Copyright All Rights ReservedRights statement
Acknowledgement required for use of an part of this reportFaculty/School
Faculty of Medicine and Health, NHMRC Clinical Trials CentreCitation
Gibbs, E., Brown, C., & Gebski, V. (2023). VESPRO: Statistical Report. University of Sydney. https://doi.org/10.25910/WTRV-G228Share